Core Points - Hangzhou Minsheng Health Pharmaceutical Co., Ltd. has signed a strategic cooperation agreement with JD Health on November 19, 2023 [1] - The company's smoking cessation drug, Minsheng Lesuke (Varenicline Tartrate Tablets), will be launched exclusively on JD Health [1] Company Summary - Hangzhou Minsheng Health Pharmaceutical Co., Ltd. is focusing on expanding its market presence through strategic partnerships [1] - The collaboration with JD Health signifies a move towards leveraging e-commerce platforms for product distribution [1] Industry Summary - The smoking cessation market is seeing increased attention with the introduction of specialized medications [1] - E-commerce is becoming a vital channel for pharmaceutical companies to reach consumers effectively [1]
民生健康戒烟药"民生乐速克"将在京东健康首发